Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001493152-22-004996
Filing Date
2022-02-18
Accepted
2022-02-18 17:00:45
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form6-ka.htm   iXBRL 6-K/A 38590
2 ex99-1.htm   iXBRL EX-99.1 717388
3 ex99-2.htm EX-99.2 158649
  Complete submission text file 0001493152-22-004996.txt   5599732

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lbps-20210630.xsd EX-101.SCH 46182
5 XBRL CALCULATION FILE lbps-20210630_cal.xml EX-101.CAL 69303
6 XBRL DEFINITION FILE lbps-20210630_def.xml EX-101.DEF 188527
7 XBRL LABEL FILE lbps-20210630_lab.xml EX-101.LAB 354414
8 XBRL PRESENTATION FILE lbps-20210630_pre.xml EX-101.PRE 303561
68 EXTRACTED XBRL INSTANCE DOCUMENT form6-ka_htm.xml XML 875133
Mailing Address 9 BOND COURT LEEDS X0 LS1 2JZ
Business Address 9 BOND COURT LEEDS X0 LS1 2JZ 44-0-113-895-0130
4D Pharma PLC (Filer) CIK: 0001830162 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-40106 | Film No.: 22653674
SIC: 2834 Pharmaceutical Preparations